AARTI PHARMALABS
Back to Balance Sheet
|
AARTI PHARMALABS Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹657 Cr | ₹694 Cr | ₹601 Cr | ₹581 Cr | ₹0.02 Cr |
What is the latest Total Current Liabilities ratio of AARTI PHARMALABS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹657 Cr |
| Mar2024 | ₹694 Cr |
| Mar2023 | ₹601 Cr |
| Mar2022 | ₹581 Cr |
| Mar2021 | ₹0.02 Cr |
How is Total Current Liabilities of AARTI PHARMALABS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹657 Cr | -5.38 | |
| Mar2024 | ₹694 Cr | 15.61 | |
| Mar2023 | ₹601 Cr | 3.44 | |
| Mar2022 | ₹581 Cr | 2,639,286.36 | |
| Mar2021 | ₹0.02 Cr | - | |
Compare Total Current Liabilities of peers of AARTI PHARMALABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI PHARMALABS | ₹6,153.1 Cr | -4.4% | -12.1% | -8.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹419,728.0 Cr | -0.8% | 7.4% | 8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,236.0 Cr | -1.5% | 5.7% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,951.0 Cr | -1.8% | 8.8% | 44.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,765.0 Cr | -1.2% | 9.2% | 14.9% | Stock Analytics | |
| CIPLA | ₹106,033.0 Cr | -2.5% | 0.1% | -7.6% | Stock Analytics | |
AARTI PHARMALABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI PHARMALABS | -4.4% |
-12.1% |
-8.7% |
| SENSEX | -3.8% |
-2% |
6.3% |
You may also like the below Video Courses